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 “How can anybody be representative for those kind of people?” Forms of patient representation in 
health research, and why it is always contestable. 
Abstract 1 
Different discourses that co-exist within the world of patient and public involvement in health and 2 
social care mirror a tangle of historical, social, political and theoretical roots. These range from the 3 
radical activism, born of civil rights movements, to a more passive model in which patients are the 4 
recipients of information. This paper explores the concept of ‘representation’ and the ways the 5 
concept is used by people serving as ‘patient’ or ‘lay’ representatives in a range of roles within 6 
research projects, funding bodies and academic institutions. We address the issue of why the 7 
representativeness of those involved is contestable. Drawing on qualitative research and engaged 8 
practice as well as on literature from social and political sciences we question how people 9 
conceptualise their own and their fellows’ acts of representation. In doing this we identify nine 10 
different conceptualisations of what it is to represent and use these to explore how judgements are 11 
made about what can count as legitimate forms of representation.  12 
Key words: England; Representation; Patient and Public Involvement; Service User Involvement; 13 
Public Engagement 14 
Why representation? 15 
In ‘The Order of Things’ (Foucault, 2007) Foucault describes Velázquez’s painting ‘Las Meninas’ and 16 
the way this represents the social relations of the Spanish Court of Philip IV. Using position, 17 
orientation, lighting and reflection the painting underlines and explores what the child at its centre 18 
represented within that society. Foucault acknowledges that his descriptions and the naming of 19 
protagonists gives additional information, but points out that he cannot tell us the same things we 20 
see in the picture. He argues this is not because either the words or the picture are more ‘true’ but 21 
because they are different, and not reducible one into to the other. What we see can never be 22 
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identical to what we say. By the same token, what we feel ourselves to be and how we imagine 1 
ourselves to represent others in concrete social situations cannot be fully captured in the language 2 
we use to describe it. 3 
Within patient and public involvement (PPI) in health research the word ‘representative’ is often an 4 
important role descriptor. Yet the role it is used to describe may vary enormously. Being a 5 
patient/service user/PPI/community ‘representative’ can suggest taking on a role in which an 6 
individual represents a broad section of the population, i.e. patients, service users, tax payers or the 7 
lay public. More narrowly an individual may act as a representative of a specific group or 8 
organisation, for example a community based support group or a charity.  In contrast organisations 9 
like these might be said to represent individuals, a whole community, a profession or a more 10 
abstract idea like ‘cancer research’ or ‘the environment’.  11 
Given these different substantive acts covered by the word ‘representative’ the reason that the role 12 
of a patient or public representative in health and social care research can feel vulnerable to 13 
challenge (Beresford & Branfield, 2012) starts to become clear. While some argue that patient and 14 
public involvement promotes civil society and democratic renewal, the counter argument, that those 15 
involved are an unrepresentative minority, is also commonly heard; a debate that was discussed  in 16 
some detail by Tritter (2010).    17 
Political science literature has described a paradox at the heart of these concepts of representation: 18 
that being a representative is to make present someone or something which may not be there, 19 
making them both absent and present. This is what Pitkin has described as a ‘fundamental dualism’ 20 
(Pitkin, 1967, p9) around which our ideas of representation are constructed. One way that theorists 21 
have attempted to resolve this paradox is by imagining representation as the manufacture of an 22 
artificial presence. In this way representation, like a prosthetic limb, can be described as both 23 
‘artificial’ and ‘real’ (Runciman, 2007). 24 
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This paper maps ideas and experiences that patient, public and lay members have of providing a 1 
group or an interest with this artificial presence, and how this paradox influences the ways their 2 
activities may be viewed by others  3 
Perspectives on Patient and Public Involvement 4 
What it means to be a patient, public or lay representative in health research and care is made 5 
complex by an array of different concrete activities that are referred to under that heading. This 6 
point was made in the UK House of Commons Health Committee report on involvement in the NHS, 7 
which also argued for a clear distinction between patient involvement and public involvement 8 
(House of Commons Health Committee, 2007).  9 
Involvement and engagement in research may mean including people as members of steering 10 
groups, committees and funding panels or asking for their comments on information leaflets. Patient 11 
and public involvement also includes consulting patients, carers and the wider community about 12 
research priorities or particular trial proposals. People may be involved throughout research as co-13 
producers (Cameron 2015); they may be asked to collect or analyse large data sets, as ‘citizen 14 
scientists’ (e.g. www.zooniverse.org and ecsa.citizen-science.net). People are often involved in more 15 
than one activity, with multiple organisations and they may act tactically in connecting and shaping 16 
their different involvement opportunities (Renedo & Marston, 2015).  17 
Researchers might choose to involve people in order to help ground their research design in the 18 
reality of patient experience, to improve recruitment to a trial or to support dissemination. For some 19 
researchers it is a matter of principle that publicly funded research should include patient and public 20 
representation. There has also been support for patient and public involvement and engagement 21 
from funders who highlight its potential to provide insights and information which can enhance 22 
relevance, implementation and impact or because it can improve governance and support 23 
legitimation (e.g. see NIHR, undated and RCUK, 2010). ‘Engagement’ is sometimes seen as more 24 
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passive than ‘involvement’, the former being a model in which patients or the public receive 1 
information or education rather than actively contributing (INVOLVE, 2017). 2 
Many active patient or carer campaigners tell of a more contested history of struggle for voice and 3 
recognition. Patient safety campaigners are now part of a recognised social movement (Williamson, 4 
2010), one that has learned from other civil rights movements highlighting inequality and power. 5 
Social movements have often challenged boundaries between the personal and the political. 6 
Feminism targeted medicine for treating women’s bodies and behaviour as abnormal, because they 7 
were not the same as those of men (Ehrenreich & English, 2005). Other paradigms of normality were 8 
challenged by the disability rights movement, through the social model of disability (Oliver, 1983) 9 
and the mental patients’ liberation movement (Alvelo, 2009) with antipsychiatry (Cooper, 1967). 10 
The gay rights movement also had a profound impact on involvement in health. There was a 11 
prolonged and colourful international campaign for the removal of homosexuality from the World 12 
Health Organisation’s International Classification of Diseases and the US Diagnostic and Statistical 13 
Manual of Mental Disorders (King et al., 2004; McLaren, 1999). This campaign can be seen as an 14 
important landmark which demonstrated that definitions of ‘illness’ can be challenged by political 15 
action, and therefore that scientific ‘truth’ can be altered by public protest. The model of direct 16 
action and established networks of gay rights activists empowered people affected by HIV AIDS to 17 
challenge medical research they felt was not addressing issues of vital importance to them. This 18 
campaign made significant contributions to research methodology in that field (Epstein, 1996). 19 
So, rather than a clearly defined phenomenon, patient and public involvement can be seen as a 20 
collection of practices which take place as part of political and administrative processes, often in a 21 
context in which the distribution of power is being contested (Contandriopoulos, 2004). In this paper 22 
we use empirical data from a study looking at theoretical approaches to participants’ experiences of 23 
patient and public involvement in health research (Maguire, 2014) to address two serious questions 24 
at the heart of the idea of patient and public involvement:  25 
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• in what ways do people understand their roles or actions as representation? 1 
• how can these understandings help us to assess the legitimacy of representation in health 2 
research and care? 3 
Study methods 4 
The overarching research question for the study was “What motivates and sustains patient and 5 
public involvement from the perspective of lay participants?” The study was undertaken as a 6 
doctoral study by a service user researcher and, as well as data from in depth interviews the study 7 
included autoethnographical reflections and continuous engagement with a patient and public 8 
involvement group (The Peninsula Public Involvement Group, PenPIG) throughout the study 9 
(Maguire, 2014).  Ethical approval for the study was granted by the Peninsula College of Medicine 10 
and Dentistry Ethics Committee in 2011.  11 
A sampling frame for interviews was constructed from respondents to a questionnaire, available 12 
online or as a hard copy and circulated through networks maintained by the National Institute for 13 
Health Research and through the patient and public involvement leads in 32 universities in England, 14 
from a list obtained from the Royal College of Nursing. The survey received 105 responses; 30 15 
respondents did not wish to participate in further parts of the study; two did not live or work in 16 
England and five were eliminated as they were academics or clinical researchers managing or 17 
working with lay participants. This produced a sampling frame of 68.  18 
Invitations to take part in interviews were sent to 34 people from this frame. These were chosen in 19 
order to maximise variation in terms of involvement experience, activities undertaken, and 20 
organisational structures.  Four invitations did not elicit any response, two people initially  agreed to 21 
be interviewed but did not respond to subsequent communications, three were unable to set a 22 
mutually convenient appointment, two had to cancel and one did not attend on the day. Ten people, 23 
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identified by other interviewees as key informants, were contacted directly; eight of these agreed to 1 
be interviewed.  2 
A total of thirty one participants were interviewed, 23 female and 8 male. Three interviewees had 3 
not been actively involved in health research at the time of contact. One of these became involved in 4 
a project advisory board during the study. Two interviewees had been members of a patient 5 
research group previously but were no longer involved in research. One of these had specifically 6 
withdrawn from research involvement to focus on service improvement and governance. Most 7 
interviewees, had been involved in a number of roles in health research, health service 8 
development/governance, and/or patient/carer support groups.  9 
Interviews took place, either face to face or over the telephone, between summer 2012 and early 10 
2013. Interviewees were sent an information sheet, consent form and a topic guide in advance. 11 
Signed consent forms were returned by post, email or in person. The topic guide explained that we 12 
wanted to discuss the duration and scope of participants’ involvement; their motivations and 13 
aspirations for these activities; perceived costs and benefits; learning gained from involvement; and 14 
feelings about research. This was not a questionnaire and participants were invited to tell their own 15 
story about involvement rather than responding directly to questions. All interviews were audio 16 
recorded, with permission, and transcribed. All interviewees were offered an opportunity to edit or 17 
comment on either a verbatim transcript or a version edited to remove repetitions and stumbles, to 18 
make text more readable (Bourdieu, 1999).  19 
Analysis took place alongside data collection. Analytic codes and categories were constructed from 20 
the data (B. Glaser, 1978; B. G. Glaser & Straus, 2012; Strauss, 1987). Some transcripts were 21 
independently coded by members of the supervisory team and discussed to reach a consensus on 22 
coding. Emerging themes and anonymised illustrations from the data were also shared with the 23 
public involvement group for comment and discussion. ‘Representation’ was identified as a major 24 
theme early on, arising from both survey and interview data, and drawing on Pitkin (1967) 25 
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representative acts and roles were categorised as either ‘acting for’ or ‘standing for’. On this basis 1 
we identified sub categories through which these activities and roles were claimed to be legitimate, 2 
or sometimes were challenged. ‘Acting for’ included the sub categories of: defending interests either 3 
by petitioning authority in a particular cause or by consciously imagining yourself in the role of those 4 
being represented and arguing from that perspective; being authorised by the organisation through 5 
a formal appointment process; being authorised by those represented, either through election or 6 
nomination; and being accountable or answerable to those being represented, either formally or 7 
informally. ‘Standing for’ included: symbolising or personifying a group or entity; sharing a particular 8 
experience, characteristic, illness or disability with the represented group; or being statistically 9 
similar to the represented population. These are shown in table 1. 10 
This study began from the perspectives of the people involved. The focus was on how their personal 11 
motivations, goals and experiences might shape their involvement. This meant that the rigid 12 
conceptual distinction between involvement in health research and involvement in health services 13 
became incoherent. This distinction between research and care is an important element of good 14 
governance, and so is rightly of vital concern to professionals and institutions. But the boundary 15 
between health service research and the provision of services is often not seen as important from a 16 
patient perspective.  Many of the patient and public roles in research focus on improving safety and 17 
care. As one interviewee, who we will call ‘Elizabeth’, said ‘most people are practical aren’t they?’ 18 
In order to safeguard confidentiality all the interviewee names used in this paper are pseudonyms. 19 
Also the names of the organisations they are involved with and any specific medical diagnoses they 20 
revealed have been removed. 21 
Results 22 
The terms ‘representative’ or ‘rep’ were widely used by interview participants, with some using 23 
them frequently throughout their interview, to describe themselves and/or others. Most used the 24 
term in a way which implied a role description they found comfortable and self-explanatory. For 25 
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others representation was experienced as a complicated and knotty concept, something that they 1 
may be challenged about, or that they feared they might fail to fulfil. 2 
One participant who explicitly used multiple concepts of representation was Oliver, a member of the 3 
lay advisory group for one of the Medical Royal Colleges which deal with standards of care and 4 
medical education for particular specialisms. Oliver was also an academic sociologist. During his 5 
interview Oliver not only spoke of his role as representing patients, he also described the College 6 
both as representing the abstract construct of the specialism and as representing a particular 7 
professional group. These roles may often coincide, but potentially they could conflict. For example, 8 
a move to shift decision making from doctors to nurses or managers, or from professionals to service 9 
users, could be in the interest of the specialism, but may not be welcomed by the doctors. These 10 
issues of who is representing and who or what is being represented add to the layers of complexity 11 
when analysing what people say about their roles and activities. 12 
The following sections will describe the categories of representation in more detail with illustrations 13 
from the data. 14 
Acting for 15 
Defending interests  16 
Representation as defence of a particular interest or group was identified in two different forms. The 17 
first is in the sense of ‘making representations’. Specifically this refers to formal statements or 18 
petitions made to a body or individual in a position of authority.  19 
Oliver provided one example of this when he described how, in his role as a member the lay panel of 20 
a Medical Royal College, he accompanied the president of that College to the Department of Health 21 
for meetings during consultations about the Health and Social Care Act. In attending these meetings 22 
Oliver talked about making representations to the minister as “someone who's not a physician” but 23 
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who was capable of presenting a case about why the College “didn’t think [the Act] was a terribly 1 
good idea.” [Interview] 2 
At a more local level Phoebe, as a service user co-applicant, accompanied research staff to a meeting 3 
of their regional Research Ethics Committee to explain why the team were resisting some protocol 4 
changes that had been suggested. 5 
“I just knew that this project should… you know, should get past the Ethics, there was no way that it 6 
should be changed at all and that it was them that didn’t understand, so I was going to go and say 7 
whatever I felt was relevant.” [Interview] 8 
Phoebe had been supporting the development of a research protocol looking at a service for 9 
patients who were both vulnerable and poorly connected to health services. She saw the Research 10 
Ethics Committee as very distanced from this group and as lacking understanding of their needs. She 11 
saw her role as persuading them that that a particular approach was necessary to support 12 
participants, rather than the complex pro forma paperwork that was being requested. In this Phoebe 13 
was defending both the interests of the research participants and those of the research team. 14 
The second form of representation as defending interests is described here by Jennifer, an 15 
interviewee with wide experience of different involvement roles. For her patient and public 16 
representation is an imaginative act of: 17 
“Putting yourself in somebody else’s shoes and saying: ‘if I were this person in this piece of research 18 
what is it going to mean to me, how would I want to be treated, what do I need to understand?’ and 19 
all those things.” [Interview] 20 
This concept of representation requires the capacity to go beyond personal testimony or the ability 21 
to present a case for a particular group with whom you are familiar. Wearing “somebody else’s 22 
shoes” may not draw upon individual health care or research experience. In fact, rather than calling 23 
on your own feelings or preferences, this form of representation could mean overcoming or masking 24 
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your feelings in order to present a case for someone in a very different position from yourself. 1 
Therefore, Jennifer argues, representation in health research is a role that requires particular skills 2 
and aptitudes.  3 
“There are people that are good at, at, at being PPI representatives, there are people that are good 4 
at, at, at, running support groups, there are people who are good at providing helpline information 5 
and - they’re not necessarily the same people.” [Interview]  6 
In identifying different concepts and activities that can be described as representation, it is worth 7 
also questioning whether people who are good at acting as a representative in one capacity, may 8 
lack the skills or aptitude for another, and vice versa. Even within this category of defending 9 
interests the specific roles and activities described differ significantly. 10 
Authorised representation 11 
How people were selected to these or other representative roles was often talked about as an 12 
important factor. A formal mechanism through which people were chosen and given authority to 13 
act, where this existed, was important in legitimising the role of a representative. One way of 14 
obtaining authority to act was through an appointment system that was recognised as legitimate. 15 
Some had responded to an open advertisement, posted either locally or nationally, for at least one 16 
of their involvement roles. Some of these also described a formal process of application and 17 
interview. This process was seen as providing legitimacy through the authority of the organisation 18 
they were involved with, in a similar way to the authorisation given to the organisation’s employees. 19 
Both Oliver and Jennifer suggested that this sort of process often failed to reach broadly enough 20 
across society, by privileging those with professional or academic backgrounds and failing to address 21 
the marginalisation of some communities. Another critic of formal interviews was David, although 22 
that was how he had initially become involved. Since then, his experience of different recruitment 23 
processes had led him to become a champion for informal open invitations.  24 
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“Interviews are bloody silly… and anyway you’re choosing people, you want to balance and so on 1 
and so forth and you choose them when you can find them, which I think is perfectly valid.” 2 
[Interview]  3 
Few participants spoke of any formal elective process. Amy described being “voted in” as trustee on 4 
the board of a national service users’ charity, a body which included both representatives elected 5 
from the membership and external co-optees. Both Amy and John also talked about elections to 6 
posts like chair, vice-chair and treasurer within patient groups.   7 
Another mechanism by which people became representatives was through being nominated by one 8 
group to represent the organisation or their membership in a different body or project. Amy was 9 
asked, as elected trustee of the charity, to act as service user representative on the governing body 10 
of an organisation representing service providers. Kate was nominated by a charity with which she 11 
acted as an Expert Patient tutor, to represent them on a research project steering group. 12 
Accountable representation 13 
Few formal mechanisms for accountability or feedback from patient and public representatives to 14 
others were identified. Some involvement groups which met regularly had a standing agenda item 15 
that enabled members to speak about projects or activities they had been involved in. People also 16 
fed back informally, often by email and some were very active on social media.  17 
Most interviewees had been invited or co-opted by researchers or clinicians into at least one of the 18 
groups or projects they were involved with. This made some reluctant to describe their role in terms 19 
of representation.  An extreme of this was Alan, someone involved in a wide range of patient forums 20 
and panels as well as research projects. He deliberately chose to describe his role as a ‘public 21 
contributor’. He argued that this role was fundamentally different from acting as a representative. 22 
Acknowledging his behaviour was sometimes perceived as difficult and challenging by both 23 
professionals and other patient and public contributors Alan argued:  24 
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“I’ve got a code of conduct that I have to adhere to with any organisation and I wouldn’t represent 1 
an organisation if I wanted to be challenging.”  [Interview] 2 
So by using the term ‘contributor’ rather than a ‘representative’ Alan saw himself as legitimating his 3 
ability to behave in a way that sometimes upset or caused offence to others. This was not a view 4 
expressed by any other interviewees, although taking the appellation of representative frequently 5 
suggested an acceptance of some level of responsibility or accountability. 6 
Co-option, self-nomination or volunteering, was sometimes seen as legitimate, where the process 7 
was undertaken in a way that was open to challenge or contestation. In this way the representative 8 
could be seen as being accountable to those represented. For example John suggested that his 9 
representation of a patient group at meetings of their host research organisation’s governing body 10 
was legitimated by copying in the whole group when he sent an email putting himself forwards. He 11 
saw this as giving others the opportunity to object to him taking that role and to hold him to account 12 
for how he fulfilled it. A related claim of representation was also identified in a study of community 13 
representatives working with local government and service providers in Local Strategic Partnerships 14 
(Maguire and Truscott, 2006). In that study a priest who sat on the partnership as a community 15 
representative argued that this role was legitimated by the informal connection he gained with local 16 
people through ‘walking the streets’. He saw this as giving him an insight into their views and needs 17 
as well as giving local people an opportunity to question or challenge him. This is clearly a model 18 
more applicable in a small geographical community than dispersed patient/carer groups or the wider 19 
public. 20 
Both these models of accountability rely on what Runciman has called the ‘non-objection criteria’ 21 
(Runciman, 2007, p95) in which those represented are assumed by their silence to have assented to 22 
the act of representation. This non-objection seems a poor measure of accountability. People like 23 
John, feel quite comfortable putting themselves forward to represent a group of patients or service 24 
users in another arena. Once they occupy that role, other group members can find it difficult to 25 
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challenge them or hold them to account. In the same way not all parishioners may feel able to accost 1 
a priest in the streets to question his contributions to a local planning meeting. 2 
Similarly those represented may struggle to hold elected or nominated representatives to account 3 
effectively. Perhaps it is not always possible, or necessary, for there to be explicit “mechanisms 4 
through which lay members can act as representatives of broader constituencies” (Barnes, 1999, 5 
p25). Yet discomfort with Alan’s claim, that a lack of affiliation to a particular group relieved him of 6 
any accountability for his views and actions as a ‘public contributor’, leads us to see such 7 
mechanisms as desirable. This raises questions about who should be responsible for creating and 8 
maintaining these mechanisms and networks. Is accountability the responsibility of patient or public 9 
representatives themselves, or of the organisations involving them? And how could we ensure such 10 
mechanisms have a representative reach? 11 
Standing for 12 
Symbolic representation 13 
The value of a patient or public representative attending meetings with professionals, politicians or 14 
other authorities may not just be in what they say. Locock et al (2016) have highlighted the 15 
importance of symbolic capital in patient and public involvement, as the status of being a patient or 16 
a member of the public carries significant symbolic meaning.  Simply by attending in that 17 
representative role they may change the nature of the proceedings. This was Oliver’s understanding 18 
of his role in the ministerial meetings: 19 
“I had a kind of symbolic role - I was sort of decorative erm, [laugh] perhaps decorative is the wrong 20 
word to describe me but I think it, it helped them make a political point.” [Interview] 21 
In accepting the invitation Oliver saw that this was not just based on his knowledge and ability as an 22 
individual. He was also acting in some way as a banner or totem of the public as users of the health 23 
service. This explicitly evokes Pitkin’s (1967) concept of symbolic representation, representation that 24 
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does not necessarily require the representative to resemble those represented, but to act as a place 1 
marker, reminding negotiators to include their interests.  2 
This representation of patients and the public in arenas previously exclusively occupied by 3 
professionals (policy makers, researchers, clinicians and/or managers) creates artificial presence of 4 
those previously excluded. Their interests are conjured, almost metaphysically into presence within 5 
those bodies, like Banquo’s ghost in Shakespeare’s play Macbeth shaking their ‘gory locks’ at tables 6 
from which they have been completely absent in the past.  7 
A similar conjuring of artificial presence was observed during a research prioritisation meeting 8 
involving NHS and academic institutions. A service user gave powerful personal testimony about the 9 
need to research treatments for a particular population. This had the effect of shifting the focus of 10 
the meeting from clean, impersonal deliberations to the frequently messy personal impacts that 11 
illness and treatments have on people’s lives. What could have been a discussion about numbers 12 
became one about people. In this way a patient, through the act of representation, enabled ‘those 13 
who are literally absent nevertheless to make their presence genuinely felt’ (Runciman, 2007 p95). 14 
Shared experience/characteristic 15 
As well as the symbolic role of his presence in that arena, the representative described above also 16 
introduced the personal into a research arena dominated by the impersonal, professional and 17 
scientific.  This was seen as an important aspect of patient representation, explicitly drawing on 18 
personal experience as a way of illustrating and informing the development of health research and 19 
care.  20 
This is demonstrated in the way Abigail describes her changing role. As she became more integrated 21 
into an interdisciplinary research team as a service user researcher she felt she was outgrowing 22 
‘patient representation’.  23 
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“I don’t do very much actual patient representation because I’ve kind of moved beyond my 1 
experience.” [Interview] 2 
She went on to describe how this altered her relationship with the research team. 3 
“I’m not thought of as a patient representative, they don’t sort of edge round me carefully. I’m sort 4 
of treated as one of the team.” [Interview] 5 
Another service user researcher who saw the use of life experience as a central focus of patient 6 
representation was Ellie. She had done a lot of work on NHS mental health service improvement, 7 
governance and research, and was very comfortable with that role. But Ellie found involvement as a 8 
patient representative in a broader research prioritisation process took her beyond her experience 9 
in a way that caused her concern.  10 
“Having people who have the related experience is more valuable than just having a group of so 11 
called ‘lay people’…  I thought actually, I’m probably not the right person to be doing this.” 12 
[Interview] 13 
 The concept of sharing a condition as a qualification for patient representation was used by John, a 14 
member of a patient and public involvement group attached to a research body. This group included 15 
people with a range of different health and social care issues, including patients and carers. When 16 
discussing researchers seeking patient and public representatives for their projects, he identified 17 
people within the group who share a particular condition as qualifying.  18 
“Five people now who’ve got [condition] within the group. So there’s five people who can go to 19 
represent people.” [Interview] 20 
This suggests that legitimate representation within these research studies was, for John, based on 21 
sharing a particular diagnosis. He did not, for instance, include group members who have experience 22 
of the condition as carers or family members.  23 
Statistically representative 24 
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John’s ideas of legitimate representation chime with the concept of having a study sample 1 
statistically representative of the study population. Clearly this is not a measure that is completely 2 
appropriate for patient and public involvement. In terms of scale and cost a statistically 3 
representative group would often be unmanageable and prohibitively expensive 4 
Yet for some patient and public representatives, the role did imply that they should be similar to the 5 
wider population they served. Oliver most clearly articulated the burden that this interpretation of 6 
representation implied for him. He spoke of the realisation, at meetings he attended between the 7 
Medical Royal College and the Department of Health, that he was the sole representative of the 8 
specialism’s 20 million patients as “sort of paralysing”. This led him to express concerns about what 9 
it means for him to be in this role. 10 
“I always worry about that, well I'm not exactly representative. But then how can anybody be 11 
representative for those kind of people? I'm absolutely the sort of person who is consulted 'cause 12 
I'm, you know, appallingly well-educated and middle-class and white and male at the same time I 13 
think if I wasn't all of those things I wouldn't really get in the door of the Department of Health, so 14 
what you gonna do?” [Interview] 15 
Lack of diversity in patient and public involvement groups in terms of class, age, education, gender 16 
and/or ethnicity was a concern frequently raised. In terms of gender, the imbalance was most often 17 
seen as a predominance of women in patient and public involvement groups and forums. Alan felt it 18 
was important for more men to be appointed to posts supporting patient and public involvement in 19 
order to address this imbalance. 20 
“If you wanna demonstrate that you can walk the walk after you’ve talked the talk, you only have to 21 
look, the whole staffing complement [of patient and public involvement support team] are female.” 22 
[Interview] 23 
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Lack of diversity was an issue Jennifer had had tried to address in one of her patient representative 1 
roles, as lay chair of the patient liaison committee for another Medical Royal College. Her aim had 2 
been to recruit: “a) a man,  b) somebody young, and c) somebody from one of the ethnic minority 3 
groups” [Interview] 4 
Practical barriers to involvement were seen as important in limiting access to some groups. People in 5 
employment had difficulties getting time off to attend meetings. People on low incomes sometimes 6 
found often protracted waits for the reimbursement of out of pocket expenses unaffordable and 7 
people on benefits had anxieties about payments leading to them being sanctioned. Transport and 8 
travel were also mentioned as barriers, particularly for people in more rural or marginal 9 
communities. All these issues were seen as structurally disadvantaging some groups. 10 
Another way that Alan believed that he and others were excluded from opportunities to contribute 11 
was through the uneven geographical distribution of research and research funding. He spoke of 12 
being “postcode-lotteried out” of some groups and projects.  13 
For Abigail the emphasis on patients in patient and public involvement in itself led to a skewing of 14 
those involved, when compared to the general population.  15 
“You don’t actually necessarily have to be a patient to be involved in research… Sometimes I think 16 
you can lose sight of what’s normal.” [Interview] 17 
This raises the issue of the purpose and nature of any individual involvement activities. In some roles 18 
in health studies or service development projects members of the public might not have much to 19 
contribute, unless they had some specific and relevant health, care, or cultural experience.  20 
It is telling that ‘representative’ in this statistical sense was most often used to describe something 21 
that a group, organisation or individual lacked. It can be hard enough to recruit a statistically 22 
representative sample from a population for a trial. Having a statistically representative public 23 
involvement group, particularly in terms of the general population rather than patients with a 24 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
18 
 
specific condition or using a particular service, is unrealistic because of the number of people that 1 
would be required.  2 
Discussion 3 
The questions we sought to address in this paper are: 4 
In what ways do people understand their roles or actions as representation? 5 
and 6 
How can these understandings help us to assess the legitimacy of representation in health research 7 
and care? 8 
With regard to the first question, we have identified a range of different concepts and 9 
understandings; both acting for others and standing for an idea, an institution or a population. Some 10 
participants described multiple forms of representation in their involvement activities. Often the 11 
potential for their legitimacy as representatives to be challenged was implicit in their discussion of 12 
the role. Sometimes this was explicitly discussed. 13 
INVOLVE has argued the importance of making involvement opportunities accessible as broadly and 14 
as fairly as possible (INVOLVE, 2012). If health research and service development systematically 15 
excludes some groups their needs may remain unrecognised and unmet. Yet avoiding the castigation 16 
or exclusion of those who are involved for failing to be sufficiently diverse may be equally important. 17 
Refusing to value and nurture those currently contributing is unlikely to encourage more or different 18 
people to be attracted to these roles. Addressing shortfalls in the structures in place to enable and 19 
support involvement might be a better approach. 20 
In order to demonstrate a commitment to diversity, some organisations (Maguire, 2014) have tried 21 
to recruit patient and public representatives from ‘groups’ they have defined by the nine protected 22 
characteristics outlined in the 2010 Equality Act (see Equality and Human Rights Commission). Only a 23 
very brief imagining of the qualification for membership of such groups is necessary to make the 24 
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absurdity of this concept apparent. For instance you would need to include: somebody who has an 1 
age or age range; someone who is either a man or a woman; someone who has a religion or a 2 
philosophical belief; someone who has a race, colour, nationality, ethnic or national origin etc.  This 3 
conflation of diverse characteristics with group membership creates an unachievable illusion of ideal 4 
representation and disguises the criteria actually used to select representatives.  A ‘protected 5 
characteristic group’ would not be representable, i.e. ‘would not exist fully as a represented group if 6 
[the representative] were not there to incarnate it’ (Bourdieu, 1991, p204). The ‘protected 7 
characteristic group’ for ‘race’ can only exist, as a ‘group’ through the choices of those appointing its 8 
representative. These choices might be most visible from the outside by noting who is excluded. Any 9 
actual involvement based on this sort of construct is open to the accusation of being 10 
‘unrepresentative’, either because an alternately defined ‘group’ has not been included or because 11 
the boundaries defining represented ‘groups’ are contested. 12 
The range of different definitions of what it means to represent, or to be a representative, helps to 13 
explain why the legitimacy of almost any actual act of patient, public or community representation is 14 
so easy to challenge. While an act may be perfectly representative using one or more of these 15 
definitions, that same act is very likely to fail to meet the criteria of some others. It is possible for an 16 
individual acting in a single role to demonstrate a range of different ‘representations’ and yet a 17 
broad and inclusive group may be ‘unrepresentative’ in at least one dimension or sense. A lack of 18 
some form of ‘representativeness’ can probably be used to delegitimise any involvement that takes 19 
place in practice.  20 
Representation as it is enacted seems to be far too complex to be contained mechanistically within 21 
any one of these definitions. Those acting as a patient or lay representative move between roles and 22 
relationships. In championing individual studies, taking part in the assessment of research proposals, 23 
contributing to governance processes etc., public, patient or lay representatives might need to 24 
consider different conditions, individuals and interests. They may act as conduits of information 25 
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between different groups and constituencies. In doing this they may frequently have to look beyond 1 
their own experience of a condition or a service, perhaps drawing on their family’s experiences, on 2 
professional expertise, life skills, imagination and understandings of their communities.  They are 3 
also likely to need to draw on these sources of personal knowledge and skills in roles they have been 4 
elected or nominated, creating a complex web of accountability and connections.  5 
This may lead us to conclude, with Runciman that while “there is no single answer to what is to 6 
count as ‘genuine’ representation” (2007, p113), the important question to ask is when are we 7 
justified in identifying an act of representation as ‘bogus’? Avoiding the use of the word 8 
‘representative’ does not help us escape this task. Alan’s decision to call himself a ‘public 9 
contributor’ rather than a ‘representative’ did not prevent both patient and professional colleagues 10 
having concerns about his actions and lack of accountability. His behaviour was still experienced as 11 
‘standing for’ in some arenas and sometimes seen as a damaging ‘bogus’ representation of patients. 12 
Representation, as a paradoxical and artificial presence of someone or something also absent, will 13 
always be imperfect.  Pitkin’s argument that people, ideas and things can be represented in a lot of 14 
different ways, depending on what they are and the context of their representation “but not 15 
everything can be made present in every way.” (1967, p226) resonates with Foucault’s (2007) 16 
differentiation between what is conveyed by Velazquez’ painting and what words can communicate. 17 
In that case it becomes important to match the type of representation enacted to the nature of that 18 
which is being represented and to the arena of that representation.  19 
Organisations wishing to involve people normally set the rules by which people are involved and 20 
often the criteria used to judge whether or not the actions performed by those people are 21 
representative. In trying to codify a single requirement for patient and public representation 22 
organisations can end up asking for people with what Graham Martin has described as a ‘strange mix 23 
of representativeness, diversity, ordinariness, knowledge and expertise’ (Martin, 2008, p46).  24 
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Professionals have both a responsibility and an interest in shaping spaces for patient and public 1 
representation within their organisations and activities in a way that is purposeful and appropriate. 2 
It is fruitless to blame patient groups for failing to live up to criteria of representativeness which are, 3 
at best, nebulous and shifting. Professionals need to support activities and structures which enable 4 
patient and public representation to take place in different ways if they wish them to be more 5 
widely accessible. Mechanisms of feedback and accountability can be co-produced with patient and 6 
public representatives, but the resources to enable that generally sit within organisations they work 7 
with. Organisations also need to support members of those groups to identify and challenge ‘bogus’ 8 
representation, both their own and that of others.  9 
Before we criticise a group, an individual or a process for being unrepresentative, it is important to 10 
be clear what we mean by that, and to look and see if there are any other ways in which they are 11 
representative. Then we are more able to judge the appropriateness or falsity of that 12 
representation. There is a real danger of miscommunication and misunderstanding when we 13 
become preoccupied with a particular word someone may have used to describe a role or activity, if 14 
in doing so we fail to engage with meanings they are trying to convey to us. 15 
  16 
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 1 
Table 1 Examples of different concepts of ‘representation’ as legitimation 
Table 1 Examples of different concepts of ‘representation’ as legitimation 
 in interview data 
Ac
tin
g 
fo
r 
De
fe
n
di
n
g 
in
te
re
st
s 
Petitioning 
Pheobe: ‘it was them [Research Ethics Committee] that didn’t 
understand, so I was going to go and say whatever I felt was 
relevant.’ 
Walking in 
their shoes 
Jennifer: ‘if I were this person in this piece of research what is 
it going to mean to me?’ 
Au
th
o
ris
e
d 
by
 
Appointed 
by 
David: ‘I went for an interview… and went on the working party 
and that really began the story of further involvements.’ 
Elected  
by 
Amy: ‘the trustees of [national organisation representing 
service users] are voted for by the membership. ’ 
Nominated 
by 
Kate: ‘[Researchers] approached [charity] and [charity] 
volunteered me.’ 
Accountable to 
John: ‘I sent the answer back to everybody - you know to ‘all’ 
so that everybody knew that I was putting meself forward.’ 
St
a
n
di
n
g 
fo
r 
Symbolising 
Oliver:  ‘I had a kind of symbolic role… it helped them make a 
political point.’ 
Sharing 
experience/ 
condition 
Ellie: ‘Having people who have the related experience is more 
valuable than just having a group of so called ‘lay people’.’ 
Statistical  
Abigail:  ‘Sometimes I think you can lose sight of what’s 
normal.’ 
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Presents a novel alternative to traditional analyses of representation in PPI  
Builds upon theories from sociology and political science 
Draws on empirical study of PPI in research and health service improvement 
Provides nine theoretically grounded conceptualisations of representation  
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